Contact Us
Drug Search Results
More Filters [+]

Mifamurtide

Alternative Names: mifamurtide, l-mtp-pe
Latest Update: 2024-11-08
Latest Update Note: Clinical Trial Update

Product Description

Mechanisms of Action: TLR4 Binder

Novel Mechanism: Yes

Modality: N/A

Route of Administration: Intravenous

FDA Designation: None *

Approval Status: Not Approved

Approved Countries: Argentina | Austria | Belgium | Brazil | Croatia | Cyprus | Czech | Denmark | Estonia | European Medicines Agency | Finland | Greece | Hungary | Iceland | Ireland | Israel | Italy | Korea | Latvia | Lithuania | Luxembourg | Netherlands | Norway | Peru | Poland | Portugal | Romania | Slovakia | Spain | Sweden | Switzerland | Taiwan | Thailand | Turkey | Ukraine | United Kingdom

Approved Indications: None

Known Adverse Events: None

Company: Takeda
Company Location: TOKYO M0 103-8668
Company CEO:
Additonal Commercial Interests: None

Clinical Description

Map of Global Clinical Trials for Mifamurtide

Countries in Clinic:

Active Clinical Trial Count:

Highest Development Phases

Phase 2: Osteosarcoma

Trial

Phase

Trial Status

Disease

Primary Completion Date

Probability of Success
UC-0150/1704

P2

Unknown Status

Osteosarcoma

2033-09-30

SARCOME13

P2

Active, not recruiting

Osteosarcoma

2025-03-01

SARCOME-13_/_OS2016

P2

Active, not recruiting

Osteosarcoma

2023-06-12

MEMOS

P2

Terminated

Osteosarcoma

2016-11-04

Recent News Events

Date

Type

Title

09/27/2023

PubMed

 Blockade of IL-10 Signaling Ensures Mifamurtide Efficacy in Metastatic Osteosarcoma.

02/24/2023

PubMed

 Microbe-mediated intestinal NOD2 stimulation improves linear growth of undernourished infant mice.

01/01/2023

PubMed

 What has changed in the last 25 years in osteosarcoma treatment? A single center experience.

03/17/2021

News Article

 Worldwide Peptide Cancer Therapeutics Industry to 2026 - Featuring Novartis, Amgen and Pfizer Among Others

03/16/2021

News Article

 Global Peptide Cancer Therapeutics Market (2021 to 2026) - Drug Dosage, Price & Clinical Trials Insight

Did PRYZM just deliver the data you were looking for?
Did you try our Excel download too?

Now that you’ve used PRYZM, we hope you’re able to see for yourself that it was designed and developed by people who actually use this data for a living. By applying next-generation technology for aggregating and curating this info across multiple key sources PRYZM delivering the latest information at your fingertips just the way you need it and with industry leading speed and cost effectiveness.

Our subscribers enjoy unlimited searches and receive this data on their own secure instance so they can overlay any additional internal/proprietary data on top of the search results and blend that data with real-time industry intel from PRYZM. Discover how you can continue to uncover the competitive landscape and drive strategy.

Suggestions